Skip to main content

Top header menu

  • Access to EMARKET SDIR
  • English
  • Italian
Home
EMARKET STORAGE - Teleborsa

Navigazione principale

  • Regulated Press releases
  • Regulated Documents
  • Support
  • Who we are
Menu

ALL Regulated Press Releases

Home Regulated Press releases
07/30/2021 - 18:26
DIASORIN
START UP OF THE TREASURY SHARES BUY-BACK PLAN OF DIASORIN S.P.A.
07/30/2021 - 18:25
DIASORIN
AVVIO PROGRAMMA DI ACQUISTO AZIONI PROPRIE DIASORIN S.P.A.
07/30/2021 - 12:57
DIASORIN
DiaSorin: Revenues and Profitability continue upward momentum in the First Half of 2021, with Guidance raised following the acquisition of Luminex
07/30/2021 - 12:56
DIASORIN
DiaSorin: fatturato e redditività in continua crescita nel 1° semestre 2021 ed incremento della guidance a seguito dell’acquisizione di Luminex
07/23/2021 - 00:38
DIASORIN
DiaSorin: Publication of Information Document under the provisions of the art. 71of the CONSOB Regulation n. 11971/1999
07/22/2021 - 18:27
DIASORIN
DiaSorin: Pubblicazione Documento Informativo ai sensi dell’art. 71 Regolamento CONSOB n. 11971/99
06/07/2021 - 15:16
DIASORIN
Communication on total amount of voting rights
06/07/2021 - 15:15
DIASORIN
Comunicazione ammontare complessivo diritti di voto
05/25/2021 - 07:02
DIASORIN
DiaSorin: launch of the LIAISON® Quick Detect COVID Ag assay, an antigen test to detect COVID-19 infection
05/25/2021 - 07:02
DIASORIN
DiaSorin: lancio del nuovo test dell’antigene LIAISON® Quick Detect COVID Ag per la diagnosi del COVID-19
05/21/2021 - 07:01
DIASORIN
DiaSorin Releases an Assay for Rapid Identification of Mutations Associated with Circulating Variants of SARS-CoV-2
05/21/2021 - 07:01
DIASORIN
DiaSorin lancia un nuovo test molecolare per l’identificazione rapida delle mutazioni associate alle varianti del SARS-CoV-2
05/20/2021 - 08:25
DIASORIN
DiaSorin’s LIAISON® SARS-CoV-2 TrimericS IgG test receives FDA Emergency Use Authorization for the U.S. market
05/20/2021 - 08:22
DIASORIN
DiaSorin riceve l’approvazione ad uso di emergenza dalla Food and Drug Administration per il test LIAISON® SARS-CoV-2 TrimericS IgG negli Stati Uniti
05/18/2021 - 16:13
DIASORIN
Notice availability Shareholders' Meeting minutes April 22, 2021
05/18/2021 - 16:12
DIASORIN
Avviso disponibilita' verbale Assemblea degli Azionisti 22 aprile 2021
05/14/2021 - 16:09
DIASORIN
DiaSorin: significant growth in Revenues and Profitability in the first quarter 2021
05/14/2021 - 16:07
DIASORIN
DiaSorin: Fatturato e Redditività in forte crescita nel 1° trimestre 2021
04/28/2021 - 17:40
DIASORIN
DiaSorin successfully prices its offer of € 500 million Senior Unsecured Equity-Linked Bonds due 2028
04/28/2021 - 17:40
DIASORIN
DiaSorin colloca con successo il prestito obbligazionario senior unsecured equity-linked da euro 500 milioni con scadenza al 2028
04/28/2021 - 07:53
DIASORIN
DiaSorin announces its intention to offer € 500 million senior unsecured equity-linked bonds due 2028
04/28/2021 - 07:52
DIASORIN
DiaSorin annuncia l’avvio del collocamento di un prestito obbligazionario senior unsecured equity-linked per Euro 500 milioni con scadenza al 2028
04/22/2021 - 15:55
DIASORIN
DiaSorin - Shareholders' meeting April 22, 2021
04/22/2021 - 15:53
DIASORIN
DiaSorin - Assemblea degli Azionisti 22 aprile 2021

Pagination

  • First page « First
  • Previous page ‹ Precedente
  • …
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Current page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • …
  • Next page Seguente ›
  • Last page Last »

Footer menu

  • Disclaimer
  • Privacy
  • Cookies
  • Emergency assistance

Teleborsa - Logo

©Copyright 2022 Teleborsa S.r.l. No material on this site may be published, distributed, sold or reproduced in any form, whether printed or written, without the authorization of Teleborsa S.r.l.

  • Regulated Press releases
  • Regulated Documents
  • Support
  • Who we are